Arama Sonuçları - Santos Carvajal‐Gonzalez
- Gösterilen 1 - 5 sonuçlar arası kayıtlar. 5
-
1
Pharmacokinetics and pharmacodynamics of PF‐05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects Yazar: William S. Denney, Gabriele E. Sonnenberg, Santos Carvajal‐Gonzalez, Theresa Tuthill, V. Margaret Jackson
Baskı/Yayın Bilgisi 2016Artigo -
2
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver‐Targeting Acetyl‐CoA Carboxylase Inhibitor (PF‐05221304): A Three‐Part Randomized Phase 1 Study Yazar: Arthur Bergman, Santos Carvajal‐Gonzalez, Sanela Tarabar, Aditi R. Saxena, William P. Esler, Neeta B. Amin
Baskı/Yayın Bilgisi 2020Artigo -
3
Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis Yazar: Neeta B. Amin, Santos Carvajal‐Gonzalez, Julie J. Purkal, Tong Zhu, Collin Crowley, Sylvie Perez, Kristin Chidsey, Albert M. Kim, Bryan Goodwin
Baskı/Yayın Bilgisi 2019Artigo -
4
Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems Yazar: Trenton T. Ross, Collin Crowley, Kenneth L. Kelly, Anthony Rinaldi, David A. Beebe, Matthew P. Lech, Robert V. Martinez, Santos Carvajal‐Gonzalez, Magalie Boucher, Dinesh Hirenallur‐Shanthappa, Jeffrey Morin, Alan Opsahl, Sarah Regina Vargas, Kendra K. Bence, Jeffrey A. Pfefferkorn, William P. Esler
Baskı/Yayın Bilgisi 2020Artigo -
5
Decreasing the Rate of Metabolic Ketone Reduction in the Discovery of a Clinical Acetyl-CoA Carboxylase Inhibitor for the Treatment of Diabetes Yazar: David A. Griffith, Daniel W. Kung, William P. Esler, Paul A. Amor, Scott W. Bagley, Carine Beysen, Santos Carvajal‐Gonzalez, Shawn D. Doran, Chris Limberakis, Alan M. Mathiowetz, Kirk McPherson, David A. Price, Éric Ravussin, Gabriele E. Sonnenberg, James A. Southers, Laurel J. Sweet, Scott Turner, F.F. Vajdos
Baskı/Yayın Bilgisi 2014Artigo
Arama Araçları:
İlgili Konular
Medicine
Chemistry
Internal medicine
Biochemistry
Biology
Enzyme
Insulin
Pharmacology
Acetyl-CoA carboxylase
Adverse effect
Beta oxidation
Disease
Endocrinology
Fatty liver
Lipogenesis
Metabolism
Nonalcoholic fatty liver disease
Pharmacodynamics
Pharmacokinetics
Postprandial
Pyruvate carboxylase
Steatohepatitis
Steatosis
Tolerability
Agonist
Alternative medicine
Biotechnology
Diacylglycerol kinase
Fibrosis
Gastric emptying